Literature DB >> 19214913

Pathogenesis of venous thromboembolism: when the cup runneth over.

Giuseppe Lippi1, Massimo Franchini.   

Abstract

A comprehensive understanding of the pathogenesis of venous thrombosis is essential for identifying patients at increased risk and who may therefore benefit from more aggressive preventive and therapeutic measures. As for other pathologies, the pathogenesis of venous thromboembolism is multifactorial. All risk factors, either congenital or acquired, are relatively "innocent" when considered alone. However, when an individual is unlucky enough to inherit one or more abnormality, compounded in many cases by environmental hazards, that person may be propelled over a threshold that precipitates the development of thrombosis. An appropriate analogy is that where "the last drop makes the cup run over." A reinterpretation of the traditional Virchow's triad (abnormal vessel wall, abnormal blood flow, and abnormal blood constituents) was provided by Eberhard Mammen throughout his research, and this has contributed greatly to the understanding of the pathogenesis of this serious disorder. Mammen postulated immobility as the leading event, because it reduced blood flow as a result of decreased muscle contraction. The subsequent "stasis of flow" led to accumulation of blood within the intramuscular sinuses, especially of the calf, triggering hypercoagulability due to local accumulation of activated clotting factors and coagulation activation products and the simultaneous consumption of blood coagulation inhibitors. On Mammen's "hit list" nearly 20 years ago were included (among inherited abnormalities) decreased protein C, protein S, antithrombin III, plasminogen, and tissue plasminogen activator, and increased plasminogen activator inhibitor-1, whereas (among acquired predisposing conditions) surgery, trauma, previous thromboembolism, prolonged immobility and paralysis, malignancy, congestive heart failure, obesity, advanced age, pregnancy and puerperium, varicose veins, and oral contraceptives were also identified. Some two decades later, the situation has perhaps not changed so much, although studies continue to expand our knowledge of this topic, clarifying the relative contribution of each single risk factor in the pathogenesis of venous thrombosis.

Entities:  

Mesh:

Year:  2009        PMID: 19214913     DOI: 10.1055/s-0029-1145257

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  18 in total

Review 1.  Paradoxical thrombosis, part 2: anticoagulant and antiplatelet therapy.

Authors:  Giuseppe Lippi; Emmanuel J Favaloro; Massimo Franchini
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

Review 2.  Paradoxical thrombosis part 1: factor replacement therapy, inherited clotting factor deficiencies and prolonged APTT.

Authors:  Giuseppe Lippi; Emmanuel J Favaloro; Massimo Franchini
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

3.  Incidence of deep venous thrombosis in Chinese patients undergoing arthroscopic knee surgery for cruciate ligament reconstruction.

Authors:  Jiang-tao Dong; Xin Wang; Xiao-qian Men; Xiao-feng Wang; Xiao-zuo Zheng; Shi-jun Gao
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-11-02       Impact factor: 4.342

Review 4.  Biochemical markers for the diagnosis of venous thromboembolism: the past, present and future.

Authors:  Giuseppe Lippi; Gianfranco Cervellin; Massimo Franchini; Emmanuel J Favaloro
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

Review 5.  The evolution of anticoagulant therapy.

Authors:  Massimo Franchini; Giancarlo M Liumbruno; Carlo Bonfanti; Giuseppe Lippi
Journal:  Blood Transfus       Date:  2015-12-16       Impact factor: 3.443

6.  Behçet's Disease as a Model of Venous Thrombosis.

Authors:  Micaela La Regina; Armen Yuri Gasparyan; Francesco Orlandini; Domenico Prisco
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

Review 7.  The role of ethnicity, age and gender in venous thromboembolism.

Authors:  Martina Montagnana; Emmanuel J Favaloro; Massimo Franchini; Gian Cesare Guidi; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

Review 8.  Alcohol consumption and venous thromboembolism: friend or foe?

Authors:  Giuseppe Lippi; Camilla Mattiuzzi; Massimo Franchini
Journal:  Intern Emerg Med       Date:  2015-10-07       Impact factor: 3.397

Review 9.  Rare thrombophilic conditions.

Authors:  Gian Luca Salvagno; Chiara Pavan; Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2018-09

10.  Experimental Validation of Methods for Prophylaxis against Deep Venous Thrombosis: A Review and Proposal.

Authors:  Paul S Agutter; P Colm Malone; Ian A Silver
Journal:  Thrombosis       Date:  2012-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.